Figure 3.

Time profile of A, mean FPG and B, mean HbA1c levels: Subgroup analysis according to MetS status for pool of phase 3 studies (safety population). Abbreviations: FPG, fasting plasma glucose; HbA1c, glycated haemoglobin; MetS, metabolic syndrome; SD, standard deviation. Figures show combined pools for ezetimibe and placebo control pools, as differences between alirocumab and control were similar in both pools. Last value defined as the last value collected up to 21 days after the last double‐blind study treatment